The innovation ecosystems within the Healthcare and life sciences (HCLS) industry are filled with a plethora of connected digital devices and systems – from laboratory information systems (LIMS) to critical IT systems containing molecular structure, or pivotal distributed clinical trial data, or even real world data (RWD) containing the clinical field performance essential to evaluate the outcomes generated by a newly approved molecule. Through all this, researchers are tasked with rapidly advancing innovation and bringing cures to the market – made fully possible only because the data and digital systems are fully secure and trusted. Additionally, the HCLS industry utilizes data, AI/ML augmented models, and other advanced digital techniques in a significant manner to push scientific and clinical frontiers. Such advancements in the past have resulted in advanced therapies, designing and executing novel clinical trials, and pioneering clinical decision support systems.
The HCLS industry has been rightfully singularly focused on innovating and bringing new molecules, products and services, while ensuring every system remains safeguarded against cyber threats. This delicate juggling act becomes especially urgent for research labs – private, universities, and government research centres. Cyber security of these systems become critical – especially since a lot of these validated systems rely on aged legacy systems to perform several vital tasks. These high-tech systems often rely on legacy infrastructure never designed to tackle, increasingly sophisticated cyber threats.
The question remains: Can your labs and research systems truly withstand a potential cyber breach? If the answer is anything less than an emphatic “yes,” it’s time to consider a shift toward a breach ready, operationally resilient model that keeps pace with rapid innovation. A Zero Trust architecture delivers the operational resiliency – and a pervasive, software defined microsegmentation is the simplest, fastest, cost-effective, and elegant way to ensure a Zero Trust architecture.
Implementing Anti-Threat Measures Often Lags Behind
Some healthcare and life sciences companies assume that hackers target only well-known hospital chains. Others see cybersecurity as purely a compliance matter, ticking boxes for HIPAA, GDPR, or other regulations, without fully appreciating how cyber breaches can derail critical research timelines, critical clinical trial deadlines. The best-case scenario for such a breach could be a hack induced delay in the completion of the project. The worst-case scenario for such a breach could either be a rapid exfiltration of years of painstakingly collected/processed research data, or worse yet contamination of the scientific data, resulting in a spurious data set.
A siloed approach where the CIO manages general IT operations and the CISO focuses solely on digital security is gradually proving unsustainable. Hackers don’t differentiate between roles. They see a unified attack surface. Protecting the core research and clinical data, be it critical scientific data, or patient trial data, or patient specific information used for personalized AI-driven diagnostics or proprietary formulations in drug discovery, requires an enterprise-wide unified approach.
An Example of Breach-Ready Posture
One leading biotechnology company recently faced the pressing question of whether they could contain a cyber breach and still continue daily operations if the worst occurred. Despite their rich history of innovation, they recognized that research also demands a cyber-resilient security posture. They realized that they needed to operate normally, even if their systems were breached. They did not want to lose any data to exfiltration, even if they were breached. This realization brought them to ColorTokens, where they built a Zero Trust architecture by adopting a pervasive microsegmentation approach to stopping lateral movement and isolating critical systems.
In practice, this shift yielded immediate benefits:
- Ensuring Operational Resilience
Vital research operations stayed online, allowing scientists to retain momentum in studies of new formulations and patient-care technologies. - Preserving Business Continuity
By preventing lateral movement across interconnected systems, they ensured a Zero Trust architecture, and ensured that isolated breaches would remain contained, reducing potential harm to a fraction of its original scope. - Maintaining Ongoing Research
Even if hit with threats, clinical trials and laboratory activities would continue uninterrupted, demonstrating that the pace of scientific progress would not be compromised. - Securing Sensitive Data
They protected both patient information and proprietary research findings, ensuring no unauthorized access could disrupt or compromise ongoing work.
This biotech organization now operates in a new paradigm of Zero Trust security, where threats are contained proactively before they morph into crippling data breaches. Their experience proves that true protection doesn’t halt innovation. On the contrary, it upholds and accelerates it.
Protecting Research in Legacy Environments
Many labs still run on a mix of legacy IT systems and LIMS (laboratory information management systems) originally built for function, not security. In parallel, overlapping operational technology (OT) networks like those monitoring critical lab equipment compound the risk when not properly segmented.
Microsegmentation stands out as a powerful strategy here. By dividing a network into distinct micro-segments and requiring strict access controls, you ensure that even if bad actors infiltrate one section, they cannot traverse freely. Such pervasive microsegmentation was not possible earlier with the solutions available then. Firewalls are good at regulating points of entry; but do not prevent lateral movement once inside the firewall. VLANs provide security by isolating segments within the larger network; but they do not prevent lateral movement within the network. EDRs are reactive and are not proactively responding to threats; and do not prevent lateral movement within the network. This is where innovations like our pervasive microsegmentation become relevant and valuable. Solutions like our XshieldTM Enterprise Microsegmentation Platform makes preventing the lateral movement feasible but also scalable, delivering:
- Network traffic visibility across heterogeneous environments
- Isolation of High-Value Assets in a manner that aligns with how researchers actually work
- Software-Defined network Controls adaptable to new threats and compliance updates
These capabilities address an often-overlooked truth. The most promising scientific endeavors can come to a standstill if a breach compromises either the data itself or the integrity of the entire research ecosystem.
Toward Operational Resiliency
The future belongs to teams who function as resiliency teams, ensuring research laboratories can continue daily operations despite potential intrusions. This type of operational resiliency is about preserving progress. Whether you’re on the verge of a breakthrough in molecular modeling or analyzing patient data to refine AI-driven predictive algorithms, you don’t want a single cyber incident to force a halt or compromise valuable findings.
When optimizing for operational resiliency, consider these:
- Adopt a Resiliency Mindset
Prepare your infrastructure to withstand attacks without sacrificing core functionalities, ensuring clinical trials or lab experiments proceed uninterrupted. - Identify Critical Assets
Map out which datasets, systems, and applications are most essential to your operations. These high-value targets warrant the strictest protections. - Leverage Microsegmentation
Limit lateral movement with network segmentation that keeps threats contained. This approach is especially crucial in environments mixing IT and OT systems. - Prioritize Proactive Monitoring
Deploy advanced threat detection and rapid-response systems that spot anomalies early before they escalate into critical breaches. - Engage in Ongoing Training
Security awareness among staff, including scientists, lab technicians, and administrators, helps close gaps that attackers often exploit.
Moving Forward with Confidence
By learning from this biotech organization’s experience, labs and research centers have a tangible roadmap to protect their most valuable assets (intellectual property, proprietary data, and patient information) while staying focused on their mission of scientific discovery.
At ColorTokens, we’re proud to partner with visionary organizations eager to align innovation with robust cybersecurity. Our XshieldTM Enterprise Microsegmentation Platform offers a straightforward principle: focus on breakthroughs, trust in a breach-ready posture that keeps your labs and research centers running normally, no matter what. Because of our unique approach, we’re honored to be the only vendor recognized in the Forrester Wave™ with top ratings for OT, IoT, and Healthcare security.
In a domain where advanced research and life-saving treatments move at an extraordinary pace, ensuring operational resiliency is both a moral and strategic imperative. If you’re ready to explore how a holistic, breach-ready model can protect your labs and research centers, I invite you to connect with us.
